Amanote Research
Register
Sign In
Identification and Mitigation of Reactive Metabolites of 2Aminoimidazole-Containing Microsomal Prostaglandin E Synthase1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury
doi 10.1021/acs.jmedchem.7b01806.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Drug-Induced Liver Injury Due to Varenicline: A Case Report
BMC Gastroenterology
Medicine
Gastroenterology
Drug-Induced Liver Injury
Medicine
Medicine
Drug-Induced Liver Injury
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Drug-Induced Liver Injury
AACN Advanced Critical Care
Medicine
Critical Care Nursing
Emergency Medicine
Review Article: Drug-Induced Liver Injury in Clinical Practice
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Avoiding Drug-Induced Liver Injury
Pharmacy Today
In Silico Observation of the Conformational Opening of the Glutathione-Binding Site of Microsomal Prostaglandin E2 Synthase1
Drug Rechallenge Following Drug-Induced Liver Injury
Hepatology
Medicine
Hepatology
Increasing Impact of Drug-Induced Liver Injury
Clinical Liver Disease
Hepatology